Vectorized antibodies hold promise to overcome many of these limitations and provide a great opportunity for DNA and RNA technology companies to enter larger markets compared with the rare disease ...
Streaming data is not new. Kafka has existed as an open source tool for a decade. Vectorized was founded on the premise that the existing tools were too complex and not designed for today’s streaming ...
Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...
Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with a ...
AMSTERDAM & BOSTON & SEATTLE, September 18, 2025--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...
A year after AbbVie and Voyager Therapeutics teamed up on Alzheimer’s disease, they are expanding their partnership to include Parkinson’s disease and other diseases in which misfolded alpha-synuclein ...
Not all drug targets are created equal. For those that result in a tissue-specific gain-of-function, the strategy can be not-so-straightforward. That’s exactly what’s going on in some forms of ...
ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results